Carna Biosciences, Inc. announced that it expects to receive ¥13.41925 million in funding from Merrill Lynch Japan Securities Co., Ltd., Investment Arm
Carna Biosciences, Inc. (JASDAQ:4572) announced a private placement of series 18 warrants for gross proceeds of ¥13,419,250 on July 11, 2019. The company will raise funding through third party allotment method. The transaction will include participation from returning investor Merrill Lynch Japan Securities Co., Ltd., Investment Arm. The transaction has been approved by the board of directors of the company.